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Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Kidney International (2012) 82, 498; doi:10.1038/ki.2012.143
Correction to: Kidney International (2011) 79, 1370–1378; doi:10.1038/ki.2011.47
For the above referenced article, on pages 1373 and 1374, there was an error regarding the listed slopes. The order of
appearance of the two values was accidentally switched. The interpretation of the findings is unchanged by this mistake. Please
see below for the complete corrected paragraph.
Serum and urinary phosphate in relation to eGFR
Next, we plotted serum phosphate and urinary FEPi in relation to eGFR using fitted splines and tested whether there were
thresholds of eGFR at which there was a statistically significant change in their slopes (Figure 4). Log FEPi increased uniformly
across the spectrum of decreasing eGFR without a detectable threshold. In contrast, serum phosphate demonstrated a J-shaped
curve: levels declined (slope¼ þ 0.0067±0.003) between the upper range of eGFR through an eGFR of 59.1 ml/min
per 1.73 m2 (95% confidence interval: 48.6–63.9), whereas below an eGFR of 59.1 serum phosphate increased
(slope¼0.017±0.002). The results remained unchanged following adjustment for age and fasting status. These data are
consistent with the subtle decrease in serum phosphate levels in the stratum, with an eGFR of 60–69 ml/min per 1.73 m2
compared with the adjacent higher and lower strata (Table 2). Furthermore, when juxtaposed with data in Table 2, these results
indicate two phases in the serum phosphate curve (Figure 4). In the proposed first phase (eGFR 459.1 ml/min per 1.73 m2),
the subtle reduction in serum phosphate levels was observed in association with increased FGF23 and FEPi, and decreased
1,25D levels. In the proposed second phase (eGFR o59.1 ml/min per 1.73 m2), serum phosphate levels gradually increased
from their nadir, whereas FGF23 increased more sharply, FEPi continued to increase, and 1,25D decreased further.
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